• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经退行性生物标志物研究中血液和脑脊液采集与储存的标准化程序:综述

Standardized Procedures for Blood and Cerebrospinal Fluid Collection and Storage in Neurodegenerative Biomarker Research: A Comprehensive Review.

作者信息

Kwon Hyuk Sung, Kim Geon Ha, Park Sun Ah, Moon So Young, Jang Jae-Won, Park Kee Hyung, Park Young Ho, Lim Jae-Sung, Yang Dong Won, Choi Seong Hye, Kim Byeong C, Kim SangYun, Koh Seong-Ho

机构信息

Department of Neurology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.

Department of Neurology, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea.

出版信息

Dement Neurocogn Disord. 2025 Jul;24(3):162-173. doi: 10.12779/dnd.2025.24.3.162. Epub 2025 Jul 17.

DOI:10.12779/dnd.2025.24.3.162
PMID:40746339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12310336/
Abstract

Blood and cerebrospinal fluid (CSF) biomarkers are essential tools for the rapid diagnosis and monitoring of neurodegenerative diseases like Alzheimer's disease (AD). However, even minor variations in sample collection and storage procedures can significantly impact biomarker measurements, emphasizing the importance of standardized operating procedures. This review discusses the main pre-analytical factors that influence biomarker stability, outlines the best practices for blood and CSF collection and storage, and extensively analyzes recent research findings to ensure optimal reproducibility in biomarker studies. It also discusses the future directions and recommendations for enhancing biomarker research methodologies, including advancements in automated processing and quality control measures.

摘要

血液和脑脊液(CSF)生物标志物是快速诊断和监测阿尔茨海默病(AD)等神经退行性疾病的重要工具。然而,即使样本采集和储存程序的微小变化也会显著影响生物标志物的测量,这凸显了标准化操作程序的重要性。本综述讨论了影响生物标志物稳定性的主要分析前因素,概述了血液和脑脊液采集与储存的最佳实践,并广泛分析了近期的研究结果,以确保生物标志物研究具有最佳的可重复性。它还讨论了增强生物标志物研究方法的未来方向和建议,包括自动化处理和质量控制措施的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c796/12310336/3b1d219788bf/dnd-24-162-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c796/12310336/173dee416cd7/dnd-24-162-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c796/12310336/3b1d219788bf/dnd-24-162-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c796/12310336/173dee416cd7/dnd-24-162-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c796/12310336/3b1d219788bf/dnd-24-162-g002.jpg

相似文献

1
Standardized Procedures for Blood and Cerebrospinal Fluid Collection and Storage in Neurodegenerative Biomarker Research: A Comprehensive Review.神经退行性生物标志物研究中血液和脑脊液采集与储存的标准化程序:综述
Dement Neurocogn Disord. 2025 Jul;24(3):162-173. doi: 10.12779/dnd.2025.24.3.162. Epub 2025 Jul 17.
2
Guidelines for the standardization of pre-analytical variables for salivary biomarker studies in Alzheimer's disease research: An updated review and consensus of the Salivary Biomarkers for Dementia Research Working Group.阿尔茨海默病研究中唾液生物标志物研究的分析前变量标准化指南:痴呆研究唾液生物标志物工作组的最新综述与共识
Alzheimers Dement. 2025 Feb;21(2):e14420. doi: 10.1002/alz.14420. Epub 2024 Dec 30.
3
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
4
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
5
The ratio of plasma pTau217 to Aβ42 outperforms individual measurements in detecting brain amyloidosis.在检测脑淀粉样变性方面,血浆pTau217与Aβ42的比值比单独测量更具优势。
medRxiv. 2025 Jan 10:2024.12.07.24318640. doi: 10.1101/2024.12.07.24318640.
6
Short-Term Memory Impairment短期记忆障碍
7
Recent advances in the detection and management of motor dysfunction in Alzheimer's disease.阿尔茨海默病运动功能障碍检测与管理的最新进展
Psychiatriki. 2025 May 14. doi: 10.22365/jpsych.2025.012.
8
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
9
Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: a systematic review and meta-analysis.脑脊液α-突触核蛋白作为帕金森病诊断的生物标志物:一项系统评价和荟萃分析。
Int J Neurosci. 2015;125(9):645-54. doi: 10.3109/00207454.2014.961454. Epub 2014 Oct 2.
10
Effect of blood collection tube containing protease inhibitors on the pre-analytical stability of Alzheimer's disease plasma biomarkers.含蛋白酶抑制剂的采血管对阿尔茨海默病血浆生物标志物分析前稳定性的影响
J Neurochem. 2024 Sep;168(9):2736-2750. doi: 10.1111/jnc.16130. Epub 2024 May 30.

本文引用的文献

1
Comparison of plasma p-tau217 and p-tau181 in predicting amyloid positivity and prognosis among Korean memory clinic patients.韩国记忆门诊患者中血浆p-tau217和p-tau181在预测淀粉样蛋白阳性及预后方面的比较
Sci Rep. 2025 Mar 6;15(1):7791. doi: 10.1038/s41598-025-90232-8.
2
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease.阿尔茨海默病淀粉样蛋白PET和脑脊液生物标志物临床应用的考量
Alzheimers Dement. 2025 Mar;21(3):e14528. doi: 10.1002/alz.14528.
3
Differential roles of Alzheimer's disease plasma biomarkers in stepwise biomarker-guided diagnostics.
阿尔茨海默病血浆生物标志物在逐步生物标志物引导诊断中的不同作用。
Alzheimers Dement. 2025 Feb;21(2):e14526. doi: 10.1002/alz.14526. Epub 2025 Feb 5.
4
Cross-cultural validation of plasma p-tau217 and p-tau181 as precision biomarkers for amyloid PET positivity: An East Asian study in Taiwan and Korea.血浆p-tau217和p-tau181作为淀粉样蛋白PET阳性的精准生物标志物的跨文化验证:一项在台湾和韩国开展的东亚研究。
Alzheimers Dement. 2025 Jan;21(1):e14565. doi: 10.1002/alz.14565.
5
Plasma Alzheimer's disease biomarker variability: Amyloid-independent and amyloid-dependent factors.血浆阿尔茨海默病生物标志物的变异性:不依赖淀粉样蛋白和依赖淀粉样蛋白的因素。
Alzheimers Dement. 2025 Jan;21(1):e14368. doi: 10.1002/alz.14368. Epub 2024 Nov 13.
6
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup.修订的阿尔茨海默病诊断和分期标准:阿尔茨海默病协会工作组。
Alzheimers Dement. 2024 Aug;20(8):5143-5169. doi: 10.1002/alz.13859. Epub 2024 Jun 27.
7
Monitoring Patients With Dementia: Insight Into Global Trends, Innovations, and Future Directions.痴呆症患者监测:洞察全球趋势、创新与未来方向。
J Clin Neurol. 2024 May;20(3):239-240. doi: 10.3988/jcn.2024.0016.
8
2024 Alzheimer's disease facts and figures.2024 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2024 May;20(5):3708-3821. doi: 10.1002/alz.13809. Epub 2024 Apr 30.
9
Effects of certain pre-analytical factors on the performance of plasma phospho-tau217.某些分析前因素对血浆磷酸化 tau217 检测性能的影响。
Alzheimers Res Ther. 2024 Feb 8;16(1):31. doi: 10.1186/s13195-024-01391-1.
10
Effect of tube filling on plasma freezing for coagulation testing.用于凝血检测的试管填充对血浆冷冻的影响。
Res Pract Thromb Haemost. 2023 Feb 24;7(3):100092. doi: 10.1016/j.rpth.2023.100092. eCollection 2023 Mar.